title: Trial design, statins, atrial fibrillation, and prevention: four horsemen of the apocalypse--author's reply.
authors.forename: Ufuk
authors.initials: U
authors.lastname: Aydýn
authors.forename: Yusuf
authors.initials: Y
authors.lastname: Ata
authors.forename: Tamer
authors.initials: T
authors.lastname: Türk
mesh_terms: D000069059:Atorvastatin / Q000627:therapeutic use*; D001281:Atrial Fibrillation / Q000517:prevention & control*; D001026:Coronary Artery Bypass; D005260:Female; D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000627:therapeutic use*; D011183:Postoperative Complications / Q000517:prevention & control*
chemical_list: D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors; D000069059:Atorvastatin